Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kaan Kirali
Suat Nail Ömeroglu
Kemal Uzun
Vedat Erentug
Ercan Eren
Cevat Yakut
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirali, K.
Right arrow Articles by Yakut, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirali, K.
Right arrow Articles by Yakut, C.
Related Collections
Right arrow Valve disease
Asian Cardiovasc Thorac Ann 2004;12:239-245
© 2004 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTION

Evolution of Repaired and Non-repaired Tricuspid Regurgitation in Rheumatic Mitral Valve Surgery without Severe Pulmonary Hypertension

Kaan Kirali, MD, Suat Nail Ömeroglu, MD, Kemal Uzun, MD, Vedat Erentug, MD, Nilgün Bozbuga, MD, Ercan Eren, MD, Mehmet Balkanay, MD, Mete Alp, MD, Cevat Yakut, MD

Department of Cardiovascular Surgery, Ko!uyolu Heart and Research Hospital, Istanbul, Turkey

For reprint information contact: Kaan Kirali, MD Tel: 90 216 326 6969 Fax: 90 216 339 0441 Email: imkkirali{at}yahoo.com Department of Cardiovascular Surgery, Ko#uyolu Heart and Research Hospital, Kadiköy 81020, Istanbul, Turkey.

The aim of this study was to evaluate the usefulness of repairing significant tricuspid regurgitation (≥ grade 2) without severe pulmonary hypertension (≤ 50 mm Hg). Between 1993 and June 2001, 88 consecutive patients were operated on for rheumatic mitral valve disease associated with significant tricuspid regurgitation and without severe pulmonary hypertension. The severity of the tricuspid valve disease was assessed by echocardiography. Sixty-three patients had severe (≥ grade 3) tricuspid regurgitation (Group I), and 25 patients had moderate (grade 2) tricuspid regurgitation (Group II). There was no hospital mortality. six patients died during follow-up. The overall actuarial survival rate for 8 years was 92.1% ± 3.1%. Cox proportional hazard regression analysis showed that age ( p = 0.006) and pulmonary complication ( p = 0.01) were associated with increased late mortality. Freedom from death was similar in both groups at 8 years (93.1% ± 3.3% versus 88% ± 8%, p = 0.7). Severe postoperative tricuspid regurgitation (≥ grade 3), caused by the failure of tricuspid repair or leaving the valve untouched, impaired long-term survival after surgery, and actuarial survival was 96.1% ± 2.7% and 83% ± 7.8% at 7 years ( p = 0.048), respectively. Severe tricuspid regurgitation, functional or organic, should be corrected at the time of mitral valve surgery, whereas untouched functional moderate tricuspid regurgitation improves after mitral valve surgery.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. M. Bernal, D. Morales, C. Revuelta, J. Llorca, J. Gutierrez-Morlote, and J. M. Revuelta
Reoperations after tricuspid valve repair
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 498 - 503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by the Asia Publishing EXchange Ltd.